We offer you fast, flexible and focused services ranging from ‘full service’ to ‘do-it-yourself’.
Select the services you require and create the ideal mix of professional study setup, consulting, data science and training services to meet your specific needs.
EvidentIQ provides a range of Managed Services for OpenStudyBuilder that can help pharmaceutical companies streamline their metadata management process. As specialists in CDISC standards since 2003, we offer comprehensive consulting services for all issues related to the OpenStudyBuilder. These services include Migration, Consulting, and Customization.
EvidentIQ offers best-in-class RWE methodologies for observational patient studies/NIS with self-patient reported data in multiple diseases and geographical areas thanks to a direct access to a global patient platform – 500,000+ patients, 1,200+ chronic diseases. Our patient studies focus on treatment preference, quality of life, value of health, disease/treatment burden, unmet needs…using sophisticated methodologies (e-PROs, e-diaries, DCE…). We generate unique RWD/RWE to significantly help our life sciences customers support the value story of their product for HTA submission, pricing and reimbursement as well as their scientific communication with the clinical community.
Over the past years, patient centricity became a must-have for the life sciences industry. Thanks to quick and direct access to generate real-world patient insights, we help our pharma, medtech, biotech and academic partners to better understand patients’ needs at each phase of the drug/medical device lifecycle. Our patient surveys focus on patient pathway, customer understanding, disease/treatment burden, acceptability of treatment services/information needs and test of concepts for patient solutions. Our solutions propose online quantitative surveys, test of concepts and quick surveys via PatientLive platform.
All our RWE projects are backed by a strong regulatory expertise at international level. Depending on the methodology of the research and objectives of the observational study, we will support you to manage IRB submission in the US and local EC submission in Europe and other regions. Our data scientist team will develop all required material to complete the submission: Protocol Writing, Statistical Analysis Plan (SAP), Data Management Plan (DMP), Information Consent Form (ICF) and other patient study materials.
EvidentIQ offers high-level standards and services in terms of Pharmacovigilance and GDPR (General Data Prorection Regulation) compliance. We ensure that all our projets fulfill all regulatory requirements in terms of AE reporting and GDPR. Our project teams are trained and certified on our client’s Pharmacovigilance process at the beginning of each project. For any research project, eConsent is collected from patient prior to starting the study with an information notice associated. Also, consent is collected at subscription on Carenity. All patient data is confidential and is shared in aggregated form, for GDPR compliance.
HTAs, KOLs, and the pharma industry acknowledge our real-world patient data can improve patients’ outcomes. Scientific communication is key to value the results of real-world patient studies in order to support the value story of your products or share evidence with the clinical community. EvidentIQ helps you to publish the results of our real-world patient studies through abstract/poster at scientific congress and manuscript in a peer reviewed-journal. Our team of data scientists will bring our expertise to support you from medical writing to management of submission. We have conducted 100+ scientific publications based on real-world patient insights.
We use a wide range of channels to ensure proper communication of your message to our audience. With our Digital Communication service we can offer you sponsored newsletters, online banners on Carenity, Facebook posts, video interview and expert content, motion design videos and infographics.
Data Linkage is a method that helps match and merge records from different sources to get a richer dataset and more valuable evidence. EvidentIQ uses significant clinical data expertise, data science analysis, and access to Carenity patient platform, to successfully conduct state of the art data linkage studies. Our innovative data linkage capabilities combine unique self-patient reported data with biomarkers collected by a wearable/sensor through continuous monitoring, bringing RWE to the next level.
The products in our portfolio are web-based and are provided using a Customer Subscription Service model.
We offer solutions both in the private and public cloud. Depending on your requirements, hosting of our cloud services can take place on the respective continent (Europe or US).
We have extensive automated monitoring procedures in place. This in combination with the 24/7 availability of our technicians and the regularly tested Business Continuity procedures, guarantees maximum availability of our solutions.
For all our products, you can reach us for service requests or professional support (24/7) via our Hotline, via e-mail or via our Support Portal.
EvidentIQ Group GmbH Rathausmarkt 5, 20095 Hamburg, Germany.
Copyright 2024 EvidentIQ
All Rights Reserved
Commercial Register: Hamburg HRB 147319
Sales Tax Identification Number: DE312852940
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Follow us: